SCHEMBL26604643

SCHEMBL26604643

COc1cc(C)c(C[C@H](C)C(=O)OCc2ccccc2)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
ACHE P22303 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
ATM Q13315 1/20 0.41
TACR1 P25103 1/20 0.41
LMNA P02545 1/20 0.40
PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29313041 0.88 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ATACR1LMNA
SCHEMBL19861960 0.88 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ATACR1LMNA
SCHEMBL21097053 0.86 OPRK1 (0.44) TACR1
SCHEMBL265561 0.78 ALDH1A1 (0.58) ALDH1A1L3MBTL1TDP1NPC1RAB9A
SCHEMBL265176 0.78 ALDH1A1 (0.58) ALDH1A1L3MBTL1TDP1NPC1RAB9A
SCHEMBL12764099 0.78 ALDH1A1 (0.58) ALDH1A1L3MBTL1TDP1NPC1RAB9A
SCHEMBL21097056 0.77 CACNA1B (0.52) PPARGPPARATACR1
SCHEMBL22430514 0.77 NPC1 (0.45) ALDH1A1CA1CA2ACHEL3MBTL1
SCHEMBL13534745 0.75 ALDH1A1 (0.50) ALDH1A1L3MBTL1TDP1NPC1RAB9A
SCHEMBL14599839 0.75 ALDH1A1 (0.50) ALDH1A1L3MBTL1TDP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795196-B2 Mitochondria-targeting peptides STEALTH BIOTHERAPEUTICS INC. (US) 2023-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795196-B2 Mitochondria-targeting peptides HSPE1, TFAM, TNNI3 ALDH1A1 3737/4885CA1 4081/4885CA2 3386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.